


Aims to achieve an attractive level of income combined with capital growth.
| Name | % Net Assets |
|---|---|
| British American Tobacco | 4.6% |
| HSBC | 3.9% |
| Royal Dutch Shell 'B' | 3.9% |
| Centrica | 3.6% |
| AstraZeneca | 3.6% |
| GlaxoSmithKline | 3.6% |
| BP | 3.5% |
| Vodafone | 3.4% |
| Aviva | 3.1% |
| National Grid | 3.0% |
| Key | % Net Assets |
|---|---|
| 4.6% | |
| 3.9% | |
| 3.9% | |
| 3.6% | |
| 84% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 375.08p |
| Currency | GBP |
| Change | 1.80p |
| % | 0.48% |
| YTD change | 8.57p |
| YTD % | 2.34% |
| Fund Inception | 07/04/2006 |
|---|---|
| Fund Manager | Pan European Equities Team |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | £100 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research